US can’t afford fall boosters for all—even after cuts to check and PPE spending

A sign for a vaccine site stands in Staten Island on November 29, 2021, in New York City.

Enlarge / An indication for a vaccine website stands in Staten Island on November 29, 2021, in New York Metropolis. (credit score: Getty | Spence Platt)

With pandemic funding operating out, the Biden administration is repurposing $10 billion to purchase next-generation COVID-19 booster doses for the autumn, in addition to therapies, together with the anti-viral Paxlovid and monoclonal antibodies.

The funding will probably be pilfered from federal packages that help COVID-19 check availability and home manufacturing, in addition to stockpiles of important sources, corresponding to private protecting gear (PPE) and ventilators. Funding for analysis on coronavirus vaccines and new therapies may also take a success.

“These had been extremely painful selections,” White Home COVID-19 Response Coordinator Ashish Jha mentioned in a press briefing Thursday.

Learn 9 remaining paragraphs | Feedback

Related Posts

Leave a Reply

Your email address will not be published.